{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:38:55Z","timestamp":1740109135598,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00404-019-05280-z","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T16:47:10Z","timestamp":1567788430000},"page":"1023-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary peritoneal serous papillary carcinoma: a case series"],"prefix":"10.1007","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6649-0810","authenticated-orcid":false,"given":"Nikolaos","family":"Blontzos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-2933","authenticated-orcid":false,"given":"Evangelos","family":"Vafias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3106-6788","authenticated-orcid":false,"given":"George","family":"Vorgias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kalinoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-4599","authenticated-orcid":false,"given":"Christos","family":"Iavazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"5280_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(59)90287-X","author":"M Swerdlow","year":"1959","unstructured":"Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Case report. Am J Obstet Gynecol. \n                      https:\/\/doi.org\/10.1016\/0002-9378(59)90287-X","journal-title":"Am J Obstet Gynecol"},{"key":"5280_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000477","author":"EL Moss","year":"2015","unstructured":"Moss EL, Evans T, Pearmain P et al (2015) Should all cases of high-grade serous ovarian, tubal, and primary peritoneal carcinomas be reclassified as tubo-ovarian serous carcinoma? Int J Gynecol Cancer. \n                      https:\/\/doi.org\/10.1097\/IGC.0000000000000477","journal-title":"Int J Gynecol Cancer"},{"key":"5280_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.01.030","author":"CI Liao","year":"2018","unstructured":"Liao CI, Chow S, Chen L et al (2018) Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Gynecol Oncol. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.030","journal-title":"Gynecol Oncol"},{"key":"5280_CR4","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1223","author":"JD Bloss","year":"1993","unstructured":"Bloss JD, Liao SY, Buller RE et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. \n                      https:\/\/doi.org\/10.1006\/gyno.1993.1223","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5280_CR5","first-page":"813","volume":"12","author":"HG Eltabbakh","year":"1998","unstructured":"Eltabbakh HG, Piver MS (1998) Extraovarian primary peritoneal carcinoma. Cancer Netw Oncol (Williston Park) 12(6):813\u2013819 (discussion 820, 825\u20136)","journal-title":"Cancer Netw Oncol (Williston Park)"},{"issue":"1","key":"5280_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Miron A et al (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3\u20139","journal-title":"Curr Opin Obstet Gynecol"},{"key":"5280_CR7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020712-163949","author":"NN Nik","year":"2013","unstructured":"Nik NN, Vang R, Shih I-M, Kurman RJ (2013) Origin and pathogenesis of pelvic (Ovarian, Tubal, and Primary Peritoneal) serous carcinoma. Annu Rev Pathol Mech Dis. \n                      https:\/\/doi.org\/10.1146\/annurev-pathol-020712-163949","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5280_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.11.020","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Zhao P, Yemelyanova A (2011) \u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2010.11.020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5280_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.soc.2007.04.017","volume":"16","author":"E Suh-Burgmann","year":"2007","unstructured":"Suh-Burgmann E, Powell CB (2007) Cytoreductive surgery for gynecologic malignancies-new standards of care. Surg Oncol Clin N Am 16(3):667\u2013682 (x\u2013xi)","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"5280_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"5280_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4318-5","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Zhou S, Liu Y et al (2018) Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review. BMC Cancer. \n                      https:\/\/doi.org\/10.1186\/s12885-018-4318-5","journal-title":"BMC Cancer"},{"key":"5280_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374","journal-title":"Cancer Treat Res"},{"issue":"4","key":"5280_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jso.21072","volume":"98","author":"S Gonz\u00e1lez-Moreno","year":"2008","unstructured":"Gonz\u00e1lez-Moreno S, Kusamura S, Baratti D, Deraco M (2008) Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 98(4):237\u2013241. \n                      https:\/\/doi.org\/10.1002\/jso.21072","journal-title":"J Surg Oncol"},{"key":"5280_CR14","doi-asserted-by":"publisher","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","volume":"197","author":"GD Aletti","year":"2007","unstructured":"Aletti GD, Dowdy SC, Podratz KC, Cliby WA (2007) Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197:676.e1\u20137. \n                      https:\/\/doi.org\/10.1016\/j.ajog.2007.10.495","journal-title":"Am J Obstet Gynecol"},{"key":"5280_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. \n                      https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"5280_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. \n                      https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"5280_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000192407.04428.bb","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. \n                      https:\/\/doi.org\/10.1097\/01.AOG.0000192407.04428.bb","journal-title":"Obstet Gynecol"},{"key":"5280_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.02.026","author":"P Wimberger","year":"2007","unstructured":"Wimberger P, Lehmann N, Kimmig R et al (2007) Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVA). Gynecol Oncol. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2007.02.026","journal-title":"Gynecol Oncol"},{"key":"5280_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.051","author":"DS Chi","year":"2006","unstructured":"Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.051","journal-title":"Gynecol Oncol"},{"key":"5280_CR20","doi-asserted-by":"publisher","DOI":"10.5152\/jtgga.2016.15223","author":"C Iavazzo","year":"2016","unstructured":"Iavazzo C, Gkegkes ID, Vrachnis N (2016) Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy. J Turkish Ger Gynecol Assoc. \n                      https:\/\/doi.org\/10.5152\/jtgga.2016.15223","journal-title":"J Turkish Ger Gynecol Assoc"},{"issue":"3","key":"5280_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ygyno.2015.01.534","volume":"136","author":"RD S\u00f8rensen","year":"2015","unstructured":"S\u00f8rensen RD, Schnack TH, Karlsen MA (2015) H\u00f8gdall CK Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities\u2014a systematic review. Gynecol Oncol 136(3):571\u2013581. \n                      https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.534","journal-title":"Gynecol Oncol"},{"key":"5280_CR22","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11662","author":"SL Neuhausen","year":"2017","unstructured":"Neuhausen SL et al (2017) Primary peritoneal serous carcinoma in men: a rare and Non-BRCA-associated Entity. Anticancer Res. \n                      https:\/\/doi.org\/10.21873\/anticanres.11662","journal-title":"Anticancer Res"},{"key":"5280_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.10236","author":"J Hata","year":"2004","unstructured":"Hata J, Araki A, Morimoto T et al (2004) Extraovarian primary peritoneal carcinoma in a child. Pediatr Blood Cancer. \n                      https:\/\/doi.org\/10.1002\/pbc.10236","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"5280_CR24","first-page":"1387","volume":"31","author":"PR Steinhagen","year":"2011","unstructured":"Steinhagen PR, Sehouli J (2011) The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. A systematic review of the literature. Anticancer Res 31(4):1387\u20131394","journal-title":"Anticancer Res"},{"issue":"6","key":"5280_CR25","first-page":"607","volume":"39","author":"Y Sakakibara","year":"2011","unstructured":"Sakakibara Y, Endo S, Yoshida Y et al (2011) A case of serous surface papillary carcinoma of the peritoneum metastatic to the brain. No Shinkei Geka 39(6):607\u2013610","journal-title":"No Shinkei Geka"},{"key":"5280_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200412000-00015","author":"MA Recine","year":"2004","unstructured":"Recine MA, Deavers MT, Middleton LP et al (2004) Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. \n                      https:\/\/doi.org\/10.1097\/00000478-200412000-00015","journal-title":"Am J Surg Pathol"},{"key":"5280_CR27","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.2140","author":"M Nakao","year":"2009","unstructured":"Nakao M, Oguri T, Maeno K et al (2009) Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. Intern Med. \n                      https:\/\/doi.org\/10.2169\/internalmedicine.48.2140","journal-title":"Intern Med"},{"key":"5280_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-017-1134-3","author":"J Yuan","year":"2017","unstructured":"Yuan J, He L, Han B, Li Y (2017) Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review. World J Surg Oncol. \n                      https:\/\/doi.org\/10.1186\/s12957-017-1134-3","journal-title":"World J Surg Oncol"},{"issue":"6","key":"5280_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00261-003-0038-6","volume":"28","author":"SY Chiou","year":"2003","unstructured":"Chiou SY, Sheu MH, Wang JH, Chang CY (2003) Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging 28(6):815\u2013819","journal-title":"Abdom Imaging"},{"key":"5280_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s002619900446","author":"T Furukawa","year":"1999","unstructured":"Furukawa T, Ueda J, Takahashi S et al (1999) Peritoneal serous papillary carcinoma: Radiological appearance. Abdom Imaging. \n                      https:\/\/doi.org\/10.1007\/s002619900446","journal-title":"Abdom Imaging"},{"key":"5280_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.02.067","author":"JM Piek","year":"2004","unstructured":"Piek JM, Kenemans P, Verheijen RH (2004) Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol. \n                      https:\/\/doi.org\/10.1016\/j.ajog.2004.02.067","journal-title":"Am J Obstet Gynecol"},{"key":"5280_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-008-0678-4","author":"C Iavazzo","year":"2008","unstructured":"Iavazzo C, Vorgias G, Katsoulis M et al (2008) Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. \n                      https:\/\/doi.org\/10.1007\/s00404-008-0678-4","journal-title":"Arch Gynecol Obstet"},{"key":"5280_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808424","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1808424","journal-title":"N Engl J Med"},{"key":"5280_CR34","doi-asserted-by":"publisher","DOI":"10.1159\/000362857","author":"OU Unal","year":"2014","unstructured":"Unal OU, Oztop I, Yazici O et al (2014) Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the anatolian society of medical oncology (ASMO). Oncol Res Treat. \n                      https:\/\/doi.org\/10.1159\/000362857","journal-title":"Oncol Res Treat"},{"key":"5280_CR35","doi-asserted-by":"publisher","DOI":"10.1159\/000448942","author":"A Musella","year":"2016","unstructured":"Musella A, Vertechy L, Romito A et al (2016) Bevacizumab in ovarian cancer: state of the art and unanswered questions. Chemotherapy. \n                      https:\/\/doi.org\/10.1159\/000448942","journal-title":"Chemotherapy"},{"key":"5280_CR36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.0505","author":"C Aghajanian","year":"2012","unstructured":"Aghajanian C, Blank SV, Goff BA et al (2012) OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol. \n                      https:\/\/doi.org\/10.1200\/JCO.2012.42.0505","journal-title":"J Clin Oncol"},{"issue":"26","key":"5280_CR37","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","volume":"379","author":"K Moore","year":"2019","unstructured":"Moore K, Colombo N, Scambia G et al (2019) Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. Obstet Gynecol Surv N Engl J Med 379(26):2495\u20132505. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1810858","journal-title":"Obstet Gynecol Surv N Engl J Med"},{"key":"5280_CR38","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e53","author":"M Ceresoli","year":"2018","unstructured":"Ceresoli M, Verrengia A, Montori G et al (2018) Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study. J Gynecol Oncol. \n                      https:\/\/doi.org\/10.3802\/jgo.2018.29.e53","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"5280_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ Van Driel","year":"2018","unstructured":"Van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. Obstet Gynecol Surv N Engl J Med 378(3):230\u2013240. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1708618","journal-title":"Obstet Gynecol Surv N Engl J Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-019-05280-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-019-05280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:16:30Z","timestamp":1599174990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-019-05280-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5280"],"URL":"https:\/\/doi.org\/10.1007\/s00404-019-05280-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"27 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that we do not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all alive individual participants or, in case of deceased patients, from their next of kin.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}